CAPILLARY: H1 revenue rose 47%, while Adjusted EBITDA more than doubled to ₹888.8 Mn

What happened

Capillary reported that first-half FY27 revenue grew 47% year over year and Adjusted EBITDA, a measure of operating earnings before certain costs, rose 116% to ₹888.8 Mn. Both figures had a 17% margin. Annual recurring revenue rose 51%, organic net revenue retention was 116%, and FY27 guidance remained on track.

Confirmed

Global impact / market context

Faster revenue growth can increase the scale of Capillary’s business, while higher operating earnings can provide more cash to support operations or investment. The 17% margin indicates earnings kept pace with revenue on that measure, but the figures do not establish future profitability or cash generation.

Analyst inference

The supplied update presents growth across revenue, recurring revenue, and customer revenue retention, alongside a statement that full-year guidance remains on track. Together, these figures suggest momentum in the business, but the article provides no share-price response, valuation, cash-flow data, or comparison with earlier guidance.

Analyst inference

What to watch

1. Check later results for whether revenue growth and the 17% Adjusted EBITDA margin continue; sustained performance would show whether first-half gains carry through the full year. Analyst inference
2. Compare reported results with FY27 guidance in future updates; the article says guidance remains on track but gives no targets against which to measure progress. Confirmed
3. Track annual recurring revenue and organic net revenue retention in subsequent reports, since changes could signal whether recurring sales and customer spending are strengthening or slowing. Analyst inference

Evidence

• Original source link unavailable